Get the latest news, advances in research, policy work, and education program updates from HAI in your inbox weekly.
Sign Up For Latest News

Stanford scientists in Senegal hunting for schistosomiasis—a parasitic disease infecting 200+ million people worldwide—used AI to transform local field work into satellite-powered disease mapping.
Stanford scientists in Senegal hunting for schistosomiasis—a parasitic disease infecting 200+ million people worldwide—used AI to transform local field work into satellite-powered disease mapping.

In order to realize the potential of mental health AI applications to deliver improved care, a multipronged approach is needed, including representative AI datasets, research practices that reflect and anticipate potential sources of bias, stakeholder engagement, and equitable design practices.
In order to realize the potential of mental health AI applications to deliver improved care, a multipronged approach is needed, including representative AI datasets, research practices that reflect and anticipate potential sources of bias, stakeholder engagement, and equitable design practices.

This brief introduces two algorithms that can promote fairer Medicare Advantage spending for minority populations.
This brief introduces two algorithms that can promote fairer Medicare Advantage spending for minority populations.


An Amazon-backed fellowship will support 10 Stanford PhD students whose work explores everything from how we communicate to understanding disease and protecting our data.
An Amazon-backed fellowship will support 10 Stanford PhD students whose work explores everything from how we communicate to understanding disease and protecting our data.

Permeation of artificial intelligence (AI) tools into health care tests traditional understandings of what patients should be told about their care. Despite the general importance of informed consent, decision support tools (eg, automatic electrocardiogram readers, rule-based risk classifiers, and UpToDate summaries) are not usually discussed with patients even though they affect treatment decisions. Should AI tools be treated similarly? The legal doctrine of informed consent requires disclosing information that is material to a reasonable patient’s decision to accept a health care service, and evidence suggests that many patients would think differently about care if they knew it was guided by AI. In recent surveys, 60% of US adults said they would be uncomfortable with their physician relying on AI,1 70% to 80% had low expectations AI would improve important aspects of their care,2 only one-third trusted health care systems to use AI responsibly,3 and 63% said it was very true that they would want to be notified about use of AI in their care.
Permeation of artificial intelligence (AI) tools into health care tests traditional understandings of what patients should be told about their care. Despite the general importance of informed consent, decision support tools (eg, automatic electrocardiogram readers, rule-based risk classifiers, and UpToDate summaries) are not usually discussed with patients even though they affect treatment decisions. Should AI tools be treated similarly? The legal doctrine of informed consent requires disclosing information that is material to a reasonable patient’s decision to accept a health care service, and evidence suggests that many patients would think differently about care if they knew it was guided by AI. In recent surveys, 60% of US adults said they would be uncomfortable with their physician relying on AI,1 70% to 80% had low expectations AI would improve important aspects of their care,2 only one-third trusted health care systems to use AI responsibly,3 and 63% said it was very true that they would want to be notified about use of AI in their care.

This policy brief explores the complexities of accounting for race in clinical algorithms for evaluating kidney disease and the implications for tackling deep-seated health inequities.
This policy brief explores the complexities of accounting for race in clinical algorithms for evaluating kidney disease and the implications for tackling deep-seated health inequities.
